Status
Acquired by Eli Lilly on July 2, 2010
Funding Received
$55 Million in 2 Rounds from 4 Investors
Headquarters:
Cambridge, MA
Description:
Alnara Pharmaceuticals develops and commercializes orally-delivered protein therapeutics for the treatment of metabolic diseases.
Founders:
Richard Aldrich, Christoph Westphal
Categories:
Health and Wellness, Biotechnology
Website:
http://www.alnara.com

Company Details

Update
Founded:
2008
Contact:
Employees:
1 in CrunchBase

Alnara Pharmaceuticals, Inc. is dedicated to developing novel protein therapeutics for the treatment of metabolic diseases. The company's innovative approach focuses on designing effective protein therapies that can be orally delivered directly to the gastrointestinal tract without being absorbed into the bloodstream.

Current Team (1)

Update

Funding Rounds (2) - $55M

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Headquarters

    840 Memorial Drive

    Cambridge, MA 02139

    USA

Images (1)

Update
  • Aca3e31ca816dd80a659beb87c2520dd